Evidence map›Paper›PMID 31160204›Full record

ReviewThe Lancet. Neurology2019

Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.

Jeffrey R Wozniak, Edward P Riley, Michael E Charness

Abstract readReview
In one paragraph

Review in The Lancet. Neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed
37.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 308 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jeffrey R WozniakDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, USA. Electronic address: jwozniak@umn.edu.
Edward P RileyCenter for Behavioral Teratology, San Diego State University, San Diego, CA, USA.
Michael E CharnessVeterans Affairs Boston Healthcare System, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Boston University School of Medicine, Boston, MA, USA.
San Diego State University · USUniversity of Minnesota · USVA Boston Healthcare System · US

Funding

Cross-Cultural Assessment of FASDU24AA014811 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI EDWARD P RILEY · 2003 to 2026
$13.1M
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum DisordersR01AA024123 · NIAAA · UNIVERSITY OF MINNESOTA · PI GEORGIEFF, MICHAEL K., WOZNIAK, JEFFREY ROBERT · 2015 to 2025
$4.6M
ALCOHOL AND CELL ADHESIONR01AA012974 · NIAAA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHARNESS, MICHAEL EDWARD · 2001 to 2016
$2.4M
Multi-modal connectivity methods for the validation of Fetal Alcohol Spectrum Disorder diagnostic criteriaU01AA026102 · NIAAA · UNIVERSITY OF MINNESOTA · PI WOZNIAK, JEFFREY ROBERT · 2017 to 2021
$1.7M
Alcohol AntagonistsI01BX002374 · VA · VA BOSTON HEALTH CARE SYSTEM · PI CHARNESS, MICHAEL EDWARD · 2015 to 2019
–
BLRD VA I01 BX002374NIAAA NIH HHS R01 AA012974NIAAA NIH HHS R01 AA024123NIAAA NIH HHS U01 AA026102NIAAA NIH HHS U24 AA014811
6 · The paper itself

Abstract

Although prenatal alcohol exposure causes craniofacial anomalies, growth retardation, neurological abnormalities, cognitive impairment, and birth defects, fetal alcohol spectrum disorder is underdiagnosed. Global prevalence of fetal alcohol spectrum disorder is 0·77%, with a higher prevalence of 2-5% in Europe and North America, highlighting the need for increased diagnosis and treatment. However, diagnosis remains challenging because of the poor reliability of self-reported maternal drinking histories, an absence of sensitive biomarkers, and the infrequency of diagnostic dysmorphic facial features among individuals with fetal alcohol spectrum disorder. Different diagnostic systems and disagreements over criteria have slowed progress in the diagnosis and management of the disorder. Neuroimaging shows abnormalities in brain structure, cortical development, white matter microstructure, and functional connectivity in individuals with fetal alcohol spectrum disorder. These abnormalities modify developmental trajectories and are associated with deficits in cognition, executive function, memory, vision, hearing, motor skills, behaviour, and social adaptation. Promising trials of nutritional interventions and cognitive rehabilitation therapies are underway, with the aim of treating cognitive deficits in fetal alcohol spectrum disorders.

Indexed as

Cognitive DysfunctionDisease ManagementFemaleFetal Alcohol Spectrum DisordersHumansPregnancyPrevalence

Identifiers

PMID31160204
PMCPMC6995665
OpenAlexW2947856544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.